Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Lancet Oncol. 2013 Aug;14(9):873-81. doi: 10.1016/S1470-2045(13)70251-1. Epub 2013 Jul 13.
Previous studies have shown decreased pregnancy rates and early menopause in female cancer survivors; however, infertility rates and reproductive interventions have not been studied. We investigated infertility and time to pregnancy in female childhood cancer survivors, and analysed treatment characteristics associated with infertility and subsequent pregnancy.
The Childhood Cancer Survivor Study (CCSS) is a cohort study including 5 year cancer survivors from 26 Canadian and US institutions who were younger than 21 years at the time of diagnosis between Jan 1, 1970, and Dec 31, 1986, and a sibling control group. We included women aged 18-39 years who had ever been sexually active. We gathered demographic, medical, and reproductive data via a baseline questionnaire, and quantified exposure to alkylating agents and radiation therapy. Self-reported infertility, medical treatment for infertility, time to first pregnancy in survivors and siblings, and the risk of infertility in survivors by demographic, disease, and treatment variables were analysed.
3531 survivors and 1366 female sibling controls who enrolled between Nov 3, 1992, and April 4, 2004, were included. Compared with their siblings, survivors had an increased risk (relative risk [RR] 1·48 [95% CI 1·23-1·78]; p<0·0001) of clinical infertility (ie, >1 year of attempts at conception without success), which was most pronounced at early reproductive ages (RR 2·92 [95% CI 1·18-7·20], p=0·020, in participants ≤24 years; 1·61 [1·05-2·48], p=0·029, in those aged 25-29 years; and 1·37 [1·11-1·69], p=0·0035, in those aged 30-40 years). Despite being equally likely to seek treatment for infertility, survivors were less likely than were their siblings to be prescribed drugs for treatment of infertility (0·57 [95% CI 0·46-0·70], p<0·0001). Increasing doses of uterine radiation and alkylating agent chemotherapy were strongly associated with infertility. Although survivors had an increased time to pregnancy compared with their siblings (p=0·032), 292 (64%) of 455 participants with self-reported clinical infertility achieved a pregnancy.
A more comprehensive understanding of infertility after cancer is crucial for counselling and decision making about future conception attempts and fertility preservation.
National Cancer Institute, American Lebanese Syrian Associated Charities, Swim Across America.
先前的研究表明,女性癌症幸存者的妊娠率和绝经年龄提前下降;然而,尚未研究不孕率和生殖干预措施。我们调查了女性儿童癌症幸存者的不孕和妊娠时间,并分析了与不孕和随后妊娠相关的治疗特征。
儿童癌症幸存者研究(CCSS)是一项队列研究,包括 26 个加拿大和美国机构的 5 岁癌症幸存者,他们在 1970 年 1 月 1 日至 1986 年 12 月 31 日诊断时年龄小于 21 岁,以及一个兄弟姐妹对照组。我们纳入了年龄在 18-39 岁之间有过性行为的女性。我们通过基线问卷收集了人口统计学、医学和生殖数据,并量化了烷化剂和放射治疗的暴露情况。通过人口统计学、疾病和治疗变量分析了幸存者的自我报告不孕、不孕治疗、幸存者和兄弟姐妹的首次妊娠时间以及幸存者的不孕风险。
共有 3531 名幸存者和 1366 名女性兄弟姐妹对照组于 1992 年 11 月 3 日至 2004 年 4 月 4 日入组。与兄弟姐妹相比,幸存者的临床不孕(即尝试受孕>1 年仍未成功)风险增加(相对风险 [RR] 1.48 [95%CI 1.23-1.78];p<0.0001),这在早期生殖年龄更为明显(RR 2.92 [95%CI 1.18-7.20],p=0.020,在≤24 岁的参与者中;1.61 [1.05-2.48],p=0.029,在 25-29 岁的参与者中;和 1.37 [1.11-1.69],p=0.0035,在 30-40 岁的参与者中)。尽管幸存者同样有可能寻求不孕治疗,但与兄弟姐妹相比,他们更不可能被开不孕治疗药物(0.57 [95%CI 0.46-0.70],p<0.0001)。子宫辐射和烷化剂化疗剂量的增加与不孕密切相关。尽管幸存者的妊娠时间比兄弟姐妹长(p=0.032),但 455 名自我报告有临床不孕的参与者中有 292 名(64%)实现了妊娠。
更全面地了解癌症后的不孕情况对于咨询和决策未来受孕尝试和生育力保存至关重要。
美国国家癌症研究所、美国黎巴嫩叙利亚裔协会慈善基金会、游泳穿越美国。